These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 16014046)
1. Metoprolol prevents sodium retention induced by lower body negative pressure in healthy men. Wuerzner G; Chiolero A; Maillard M; Nussberger J; Burnier M Kidney Int; 2005 Aug; 68(2):688-94. PubMed ID: 16014046 [TBL] [Abstract][Full Text] [Related]
2. Angiotensin II receptor blockade prevents acute renal sodium retention induced by low levels of orthostatic stress. Wuerzner G; Chioléro A; Maillard M; Nussberger J; Brunner HR; Burnier M Kidney Int; 2004 Jan; 65(1):238-44. PubMed ID: 14675055 [TBL] [Abstract][Full Text] [Related]
3. Effects of selective angiotensin II and beta1-receptor blockade on renal haemodynamics and sodium handling during orthostatic stress in healthy individuals. Wuerzner G; Burnier M J Hypertens Suppl; 2006 Mar; 24(1):S89-93. PubMed ID: 16601579 [TBL] [Abstract][Full Text] [Related]
4. Renal and neurohormonal responses to increasing levels of lower body negative pressure in men. Würzner G; Chiolero A; Maillard M; Nussberger J; Hayoz D; Brunner HR; Burnier M Kidney Int; 2001 Oct; 60(4):1469-76. PubMed ID: 11576361 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure. Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739 [TBL] [Abstract][Full Text] [Related]
6. Effects of the angiotensin type I receptor antagonist, losartan, on systemic and regional vascular responses to lower body negative pressure in healthy volunteers. Duranteau J; Pussard E; Berdeaux A; Giudicelli JF Br J Clin Pharmacol; 1995 Nov; 40(5):431-8. PubMed ID: 8703646 [TBL] [Abstract][Full Text] [Related]
7. The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment. Braun M; Edelmann F; Knapp M; Schön S; Schwencke C; Simonis G; Borst M; Weinbrenner C; Strasser RH Int J Cardiol; 2009 Feb; 132(2):248-56. PubMed ID: 18579230 [TBL] [Abstract][Full Text] [Related]
8. Effect of 6-week endurance training on hemodynamic and neurohormonal responses to lower body negative pressure (LBNP) in healthy young men. Nazar K; Gasiorowska A; Mikulski T; Cybulski G; Niewiadomski W; Smorawiński J; Krzemiński K; Ziemba AW; Dorsz A; Kaciuba-Uściłko H J Physiol Pharmacol; 2006 Jun; 57(2):177-88. PubMed ID: 16845224 [TBL] [Abstract][Full Text] [Related]
9. Sympathetic cardiac influence and arterial blood pressure instability. Formes KJ; Wray DW; O-Yurvati AH; Weiss MS; Shi X Auton Neurosci; 2005 Mar; 118(1-2):116-24. PubMed ID: 15795185 [TBL] [Abstract][Full Text] [Related]
10. Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans. Olsen NV Dan Med Bull; 1998 Jun; 45(3):282-97. PubMed ID: 9675540 [TBL] [Abstract][Full Text] [Related]
11. Effects of angiotensin II receptor antagonism on the renal hemodynamic response to cardiovascular stress. Frank H; Schobel HP; Vitkowsky J; Schmieder RE; Heusser K Kidney Int; 2003 Feb; 63(2):617-23. PubMed ID: 12631126 [TBL] [Abstract][Full Text] [Related]
12. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial. Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026 [TBL] [Abstract][Full Text] [Related]
13. Effect of additive renin inhibition with aliskiren on renal blood flow in patients with Chronic Heart Failure and Renal Dysfunction (Additive Renin Inhibition with Aliskiren on renal blood flow and Neurohormonal Activation in patients with Chronic Heart Failure and Renal Dysfunction). Schroten NF; Damman K; Hemmelder MH; Voors AA; Navis G; Gaillard CA; van Veldhuisen DJ; Van Gilst WH; Hillege HL Am Heart J; 2015 May; 169(5):693-701.e3. PubMed ID: 25965717 [TBL] [Abstract][Full Text] [Related]
14. Effects of acute beta-adrenoceptor blockade with metoprolol on the renal response to dopamine in normal humans. Olsen NV; Lang-Jensen T; Hansen JM; Plum I; Thomsen JK; Strandgaard S; Leyssac PP Br J Clin Pharmacol; 1994 Apr; 37(4):347-53. PubMed ID: 8018456 [TBL] [Abstract][Full Text] [Related]
15. Systemic hemodynamic, forearm vascular, renal, and humoral responses to sustained cardiopulmonary baroreceptor deactivation in well-compensated cirrhosis. Wong F; Logan A; Blendis L Hepatology; 1995 Mar; 21(3):717-24. PubMed ID: 7875669 [TBL] [Abstract][Full Text] [Related]
16. [Role of prostaglandins in regulation of kidney function in heart failure]. Riegger AJ Herz; 1991 Apr; 16(2):116-23. PubMed ID: 2066053 [TBL] [Abstract][Full Text] [Related]
17. Effect of lower body negative pressure against orthostatic intolerance induced by 21 days head-down tilt bed rest. Sun XQ; Yao YJ; Wu XY; Jiang SZ; Jiang CL; Cao XS; Hao WY; Qiao ZL Aviat Space Environ Med; 2002 Apr; 73(4):335-40. PubMed ID: 11952053 [TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of beta blockade in patients with chronic congestive heart failure awaiting transplantation. Kalman J; Buchholz C; Steinmetz M; Courtney M; Gass A; Lansman S; Kukin ML J Heart Lung Transplant; 1995; 14(6 Pt 1):1212-7. PubMed ID: 8719469 [TBL] [Abstract][Full Text] [Related]
19. Effect of the Arg389Gly β₁-adrenoceptor polymorphism on plasma renin activity and heart rate, and the genotype-dependent response to metoprolol treatment. Petersen M; Andersen JT; Jimenez-Solem E; Broedbaek K; Hjelvang BR; Henriksen T; Frandsen E; Forman JL; Torp-Pedersen C; Køber L; Poulsen HE Clin Exp Pharmacol Physiol; 2012 Sep; 39(9):779-85. PubMed ID: 22703382 [TBL] [Abstract][Full Text] [Related]